Personalised medicine: Opportunities, Challenges and Sustainability

Invitation - Personalized MedicineDear Member,

The Italian Society, in partnership with the Health Society, is delighted to invite you to:

Personalized medicine: Opportunities, Challenges and Sustainability

Personalized medicine aims at identifying the best therapies for each individual against the “one-size fits all” approach to healthcare. How will regulations adapt, and is this practice financially viable? 

with Professor Guido Rasi (Executive Director, European Medicines Agency) and
Professor Costantino Pitzalis
 (Queen Mary University)

Moderated by Professor Roberto Di Lauro (Scientific Attaché, Italian Embassy in London)

Monday 22 January, 6.30-8PM

LSE Clement’s House, Room 7.02 
(265 Strand, WC2R 1DH)

The event will be followed by a drinks reception. This event is free and open to all however registration is required at the following link

Visit our website for updates and remember to follow us on Twitter @LSE_Italians and on Facebook too.

We look forward to seeing you there,

The Italian Society Committee

Speaker Biographies:

Guido Rasi began his second term as Executive Director of EMA on 16 November 2015. From November 2014 to mid-November 2015, Professor Guido Rasi served as EMA’s Principal Adviser in Charge of Strategy. From November 2011 to November 2014 he was the Executive Director of the European Medicines Agency and a member of its Management Board in the three years prior to this. He was Director-General of the Italian Medicines Agency from 2008 to 2011 and member of the Management Board from 2004 and 2008. He was made full professor of microbiology at the University of Rome ‘Tor Vergata’ in 2008. From 2005 to 2008 he was Director of Research at the Institute of Neurobiology and Molecular Medicine of the National Research Council(CNR) in Rome.  From 1990 to 2005 Professor Rasi worked at the Institute for Experimental Medicine of the National Research Council, Italy. He had a teaching and research experience at the University of California, Berkeley in 1999. Professor Rasi holds a degree in medicine and surgery, with specialisations in internal medicine, allergology and clinical immunology, from the University of Rome. From 1978 to 1990, he worked as a physician in hospital, research and private practice. He is author of more than 100 scientific publications. Prof Rasi was born in Padova, Italy and is married with two children.

Costantino Pitzalis is Professor of Experimental Medicine and Rheumatology and Head of the Centre for Experimental Medicine and Rheumatology. His clinical interests encompass general rheumatology with a focus on immune/inflammatory rheumatic diseases, including rheumatoid and psoriatic arthritis. His major research interests focus on the cellular and molecular mechanisms of inflammation and autoimmunity in chronic arthritis with particular emphasis on translational research and biomarkers discovery. He leads a Research Team of over 35 Researchers (Clinicians and Scientists) with more than £11million research income. He has produced research of international standing captured in over 140 publications (over 50 in journals with impact factor >5) in the field of inflammation, immunity and arthritis. Professor Pitzalis serves on the EULAR Scientific Committee and the Heberden Committee, British Society for Rheumatology. He is a member of the Research Grant Committee Arthritis Research UK and several other national and international committees. He serves on the Editorial Board of Annals of Rheumatic Diseases and Arthritis Research & Therapy.

Roberto Di Lauro
is full professor of Medical Genetics and he is from 2014 the scientific attachè at the Italian Embassy in London. He carried out research in the field of gene expression and embryonic development at many Italian and international institutions and authored 147 publications. He served on several science boards, including the Council of the European Molecular Biology Organization, the Fellowship Panel of the Human Frontier Science Programme (Chair), the Scientific Advisory Board of the European Molecular Biology Laboratory (Chair), and the review panel in Cellular and Developmental Biology of the European Research Council. He was President of the Zoological Station Anton Dohrn, one of the Italian Public Research Institutions, and Deputy for Research at the University of Naples Federico II. In 2007 he was awarded the title of “Commendatore” (Knight Commander) for merit by the President of Italy.